Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-07-08
1999-11-16
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514451, 514454, 514461, 514468, 604 4, A61K 3135, A61K 3134, A61M 3700
Patent
active
059859148
ABSTRACT:
A method of treating inflammatory disorders of the bowel and inflammatory disorders of the urinary bladder are disclosed. A method of modulating the function of monocytes is also disclosed. The method involves the treatment of a patient's blood with a photoactivatable compound followed by ultraviolet light-activation of the photoactivatable compound. The blood treated as such is returned to the patient in a process known as extracorporeal photopheresis.
REFERENCES:
patent: D298279 (1988-10-01), Lee et al.
patent: D298567 (1988-11-01), Morris
patent: D299531 (1989-01-01), Troutner et al.
patent: D299953 (1989-02-01), King et al.
patent: 4196281 (1980-04-01), Hearst et al.
patent: 4321919 (1982-03-01), Edelson
patent: 4398906 (1983-08-01), Edelson
patent: 4428744 (1984-01-01), Edelson
patent: 4452811 (1984-06-01), della Ville
patent: 4464166 (1984-08-01), Edelson
patent: 4464354 (1984-08-01), Bisagni et al.
patent: 4465691 (1984-08-01), Bisagni et al.
patent: 4568328 (1986-02-01), King
patent: 4573960 (1986-03-01), Goss
patent: 4573961 (1986-03-01), King
patent: 4573962 (1986-03-01), Troutner
patent: 4578056 (1986-03-01), King et al.
patent: 4596547 (1986-06-01), Troutner
patent: 4612007 (1986-09-01), Edelson
patent: 4613322 (1986-09-01), Edelson
patent: 4623328 (1986-11-01), Hartranft
patent: 4643710 (1987-02-01), Troutner
patent: 4681568 (1987-07-01), Troutner
patent: 4683889 (1987-08-01), Edelson
patent: 4684521 (1987-08-01), Wdelson
patent: 4687464 (1987-08-01), Troutner
patent: 4692138 (1987-09-01), Troutner et al.
patent: 4693981 (1987-09-01), Wiesehahn et al.
patent: 4705498 (1987-11-01), Goss
patent: 4708715 (1987-11-01), Troutner et al.
patent: 4726949 (1988-02-01), Miripol et al.
patent: 4727027 (1988-02-01), Wiesehahn et al.
patent: 4737140 (1988-04-01), Lee et al.
patent: 4748120 (1988-05-01), Wiesehahn et al.
patent: 4838852 (1989-06-01), Edelson et al.
patent: 4866282 (1989-09-01), Miripol et al.
patent: 4897789 (1990-01-01), King et al.
patent: 4921473 (1990-05-01), Lee et al.
patent: 4952812 (1990-08-01), Miripol et al.
patent: 4960408 (1990-10-01), Klainer et al.
patent: 4999375 (1991-03-01), Bachynsky et al.
patent: 5030200 (1991-07-01), Judy et al.
patent: 5176921 (1993-01-01), Wiesehahn et al.
patent: 5216176 (1993-06-01), Heindel et al.
patent: 5288605 (1994-02-01), Lin et al.
patent: 5356929 (1994-10-01), Heindel et al.
patent: 5360734 (1994-11-01), Cgaonab et al.
patent: 5399719 (1995-03-01), Wollowitz et al.
patent: 5459030 (1995-10-01), Lin et al.
patent: 5482828 (1996-01-01), Lin et al.
patent: 5651993 (1997-07-01), Edelson et al.
Richard Edelson et al. "Treatment of Cutaneous T-cell Lymphoma By Extracorporeal Photochemotherapy" New England Journal of Medicine 316:297-303 (Feb. 5, 1987).
Marglis-Nunno et al."Elimination of Potential Mutagenicity in Plantelet Concentrates that are virally Inactive with Psoralens and Ultraviolet A Light" Transformation 1985:pp. 855-862.
Hoofnagle et al. Treatment of chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha interferon New England Journal of Medicine vol. 315 No. 25 pp. 1575-1578.
Davis et al. "Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa" New England Journal of Medicine vol. 321 No. 22 pp. 1501-1505.
Di Bisceglie et al. "Recombinant Interferon Alfa Therapy for Chronic Hepatitis C" New England Journal of Medicine vol. 321 No. 22 pp. 1506-1510.
Farci et al "A Long-term Study of Hepitatis C Virus Replication in non-A, Non-B Hepatitis" New England Journal of Medicine vol. 325 No. 2 pp. 98-103.
Shindo et al. "Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C" Annals of Internal Medicine vol. 115 No. 9 pp. 701-704.
"High Dose Interferon Alfa-2A for the Treatment of Chronic Hepatitis C" The Annals of Pharmacotherapy 1994 Mar. vol. 28 pp. 341-342.
M. Gomez-Rubio et al. "Prolonged Treatment (18 months) of Chronic Hepatitis C with Recombinant .alpha.-Interferon in comparison with a control group" Journal of Hepatology, 1990:11:S63-S67.
Saez-Royuela et al. "High Doses of Recombinant .alpha.-Interferon or .gamma.-Interferon for Chronic Hepatitis C: A Randomized, Controlled Trial" Hepatology 1991; 13:No. 2 327-331.
Nakano et al. "Comparative Study of Clinical, Histological, and Immunologics Responses to Interferon Therapy in Type Non-A, Non-B, and Type B Chronic Hepatitis" The American Journal of Gastroenterology vol. 85; No. 1.1990.
Haysahi et al. "Improvement of Serum Aminotransferase Levels after Phlebotomy in Patients with chronic Active Hepatitis C and Excess Hepatic Iron" The American Journal of Gastroenterology vol. 89; No. 7.1994 pp. 986-988.
Ljunggren et al. "Plasma Levels of 8 Methoxypsoralen Determined by High-Pressure Liquid Chromatography in Psoriatic Patients Ingesting Drug from Two Manufacturers" The Journal of Investigative Dermatology, vol. 74, No. 1 pp. 59-62.
Christer T. Jansen et al. "Inter-and Intraindividual Variations in Serum Methoxsalen Levels During Repeat Oral Exposure" Therapeutic Research vol. 33, No. 2 pp. 258-264.
Micael J. Clemens et al. "Regulation of Cell Proliferation and Differentation by Interferons" Brochena J (1985) 226, 345-360.
Witter et al. "Effects of Prednisone, Aspirin, and Acetaminophen on an in vivo biologic response to interferon in humans" Clin Pharmacol Ther Aug. 1988 pp. 239-243.
Alain H. Rook et al. "Combined Therapy for Sezary Syndrome With Extracorporeal Phtochemotherapy and Low Dose Inteferon Alfa Therapy" Arch Dermatol. 1991;127: pp. 1535-1540.
Alain H. Rook, et al. "Treatment of Autoimmune Disease with Extracorporeal Photochemotherapy: Pemphigus Vulgaris" The Yale Journal of Biology and Medicine 62 (1989). 647-652.
Barr et al. "Immunomodulation with photopheresis: Clinical Results of the Multi-Center Cardiac Transplantation Study" Study supported by Therakos, A Johnson & Johnson Company.
Costanzo-Nordin et al. "Successful Treatment of Heart Transplant Rejection with Photopheresis" Transplantation vol. 53, 808-815, No. 4 Apr. 1992.
Meiser et al. Reduction of the Incidence of rejection by Adjunct Immunosuppression with Photochemotherapy After Heart Transplantation Transplantation vol. 57 563-566 No. 4 Feb. 1994.
Vowels et al. "Extracorporeal Photochemotherapy Induces the Production of Tumor Necrosis Factor-.alpha. by Monocytes: Implications for the Treatment of Cutaneous T-ell Lymphoma and Systemic Sclerosis" The Journal of Investigative Dermatology, Inc. vol. 98:686-692,1992.
Gil et al. "Hepatic and Extrahepatic HCV RNA Strands in Chronic Hepatitis C: Different Patterns of Response to Interferon Treatment Hepatology 1993; 18, 1050-1054.
Qian et al. "Replication of hepatitis C Virus in peripheral blood mononuclear cells" Journal of Hepatology 1992;16:38-383.
Elcanor C. Mandoza et al. Decreased Phorbol Myristate Acetate-Induced Release of Tumor Necrosis Factor-.alpha. and Interleukin-1.beta. from Peripheral Blood Monocytes of Patients Chronically Infected with Hepatitis C Virus Journal of Infectious Disease 1996 vol. 174 pp. 42-44.
Zignego et al. "Infection of peripheral mononuclear blood cells by hepatitis C Virus" Journal of Hepathology, 1992;15:382-386.
"Mutsunori Shirai et al. "Introduction of Cytotoxic T Cells to a Cross-Reactive Epitope in the Hepatitis C Virus Nonstructural RNA polymerase-Like Protein" Journal of Virology, Jul. 1992;pp. 4098-4106.
Kanei et al. "Supression of hepatitis C virus RNA by interferon-.lambda." The Lancet vol. 336 p. 245.
Amy J. Weiner et al. "Evidence for immune selection of hepatitis C virus (HCV) putative enveolpe glycoprotein variants: Potential role in chronic HCV infections" Proc. Natl. Acad. Sci. USA vol.. 89 pp. 3468-3472.
Shimizu et al. "Early events in hepatitis C. Virus infection of chimpanzees" Proc. Natl. Acad. Sci. USA 87 pp. 6441-6444.
J. A. Garson et al. "Enhanced detection by PCR of hepatitis C virus RNA" The Lancet Oct. 6, 1990 p. 878.
P. Simmonds et al. "Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region" Journal of General Virology (1993). 74 2391-2399.
Houghton et al
McLaughlin Susan
Stouch Bruce
Zeldis Jerome
Therakos, Inc.
Wallen, lll John W.
Weddington Kevin E.
LandOfFree
Treatment of inflammatory disorders of the bowel and urinary bla does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of inflammatory disorders of the bowel and urinary bla, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of inflammatory disorders of the bowel and urinary bla will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1325291